Concepedia

Paul A. Barsanti

PA

20

Publications

1.1K

Citations

17

H-Index

1993

Active since

Affiliations

Novartis (United States)(Current)

University of Nottingham

University of Illinois Urbana-Champaign

University of Bath

Genomics Institute of the Novartis Research Foundation

Paul A. Barsanti is an author at Novartis (United States) specializing in natural sciences, organic chemistry, and biochemistry.

Top concepts

Publications per year

1993–2019

20

Publications

20

Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction

K.R. Simonetta, Joshua P. Taygerly, Kathleen Boyle et al. · Nature Communications · 2019 · 196 citations · Full text

Enantioselective Ring Opening of Epoxides with Silicon Tetrachloride in the Presence of a Chiral Lewis Base

Scott E. Denmark, Paul A. Barsanti, Ken‐Tsung Wong et al. · The Journal of Organic Chemistry · 1998 · 176 citations

, , +11

A Synthetic Lethal Screen Reveals Enhanced Sensitivity to ATR Inhibitor Treatment in Mantle Cell Lymphoma with ATM Loss-of-Function

Daniel L. Menezes, Jenny Holt, Yan Tang et al. · Molecular Cancer Research · 2014 · 99 citations

The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5

Paul A. Barsanti, Weibo Wang, Zhi‐Jie Ni et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 98 citations · Full text

, , +8

4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors

Zhi‐Jie Ni, Paul A. Barsanti, Nathan Brammeier et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 70 citations · Full text

, , +6

Rows per page

1–5 of 20